The business side of medical practice can sometimes be a bigger challenge than ferreting out a difficult diagnosis.
More Employers Switching to ‘Consumer-Directed Health Care’ as Way to Control Costs
Plagued by annual increases in health-care premiums for their employees that regularly reach double digits, some US companies are exploring the role of consumer-directed health care with the goal of fostering healthier workers who are more accountable for their own health, thereby reducing the costs of company-provided health insurance.
The ABCs of CPT Coding
Important aspects of coding and reimbursement for otolaryngologists-head and neck surgeons-including some controversial coding issues-were covered in the American Rhinologic Society (ARS)’s Patient Advocacy Panel here at the 2006 Combined Otolaryngology Spring Meetings (COSM).
AMA’s Opt-Out Provision for Sale of Physician Prescribing Data Seen as First Step
Otolaryngologists agree with their fellow physicians who prescribe drugs-pharmaceutical companies have no business buying or using information on how and when they prescribe particular drugs, nor do they want to be confronted by pharmaceutical company representatives in their office about why they do or don’t prescribe that company’s products.
How Standard Is “Standard of Care”?
How much do your treatments and procedures vary from the established standard of care? Does it matter?
When It Comes to Drug Development, What Do Our Dollars Buy?
Two studies look at trends in the cost and length of time spent developing new pharmaceuticals
Academic Head and Neck Surgery: Educating Our Future
Despite much belief to the contrary, tobacco control has been a major public health success over the last four decades.
Situation Critical: Otolaryngologists See Diminishing Returns for Taking Emergency Call
Getting out of the Insurance Game
Transitioning to a cash-only practice can increase your income-and your career satisfaction
Prescription Drug Benefit Primer
This January, the Medicare Prescription Drug Benefit, created by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), took effect.